PTC Therapeutics | Kostnadene For Salg



Cost Of Sales Endring Dato
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
Alnylam Pharmaceuticals USD 102.82M 16.91M 2024-12
Amgen USD 3.11B 198M 2024-12
Biogen USD 583.5M 55.2M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Cytokinetics 463K 79.14M 2024-09
Daiichi Sankyo JPY 128.38B 30.35B 2024-12
Gilead Sciences USD 1.58B 7M 2024-12
Incyte USD 82.38M 2.49M 2024-12
Ionis Pharmaceuticals USD 3.83M 2.76M 2024-12
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Novartis USD 3.32B 90M 2024-12
Pfizer USD 5.65B 781M 2024-12
PTC Therapeutics USD 16.28M 5.44M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
TG Therapeutics USD 15.4M 6.06M 2024-12
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Xencor 10.71M 4.56M 2024-09



PTC Therapeutics Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.